Battacin (octapeptin B5), a new cyclic lipopeptide antibiotic from paenibacillus tianmuensis active against multidrug-resistant gram-negative bacteria

Antimicrobial Agents and Chemotherapy

Volumn 56, Issue 3, 2012, Pages 1458-1465

  Qian, Chao Dong ^a   Wu, Xue Chang ^a   Teng, Yi ^a   Zhao, Wen Peng ^a   Li, Ou ^a   Fang, Sheng Guo ^a,b   Huang, Zhao Hui ^c   Gao, Hai Chun ^a  

^a ZHEJIANG UNIVERSITY   (China)

^b BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

^c Soochow University   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BATTACIN; POLYMYXIN B; POLYPEPTIDE ANTIBIOTIC AGENT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL MEMBRANE; BACTERIUM; BIOLOGICAL ACTIVITY; CELL MEMBRANE; CELL MEMBRANE DEPOLARIZATION; CONTROLLED STUDY; DRUG ISOLATION; DRUG PURIFICATION; DRUG STRUCTURE; ESCHERICHIA COLI; GRAM NEGATIVE BACTERIUM; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MEMBRANE DAMAGE; MINIMUM INHIBITORY CONCENTRATION; MOUSE; NONHUMAN; PAENIBACILLUS TIANMUENSIS; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA;

ANIMALS; ANTI-BACTERIAL AGENTS; ANTIMICROBIAL CATIONIC PEPTIDES; BIOLOGICAL TRANSPORT; CELL MEMBRANE PERMEABILITY; CROSS INFECTION; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ESCHERICHIA COLI; FERMENTATION; HEK293 CELLS; HEMOLYSIS; HUMANS; KINETICS; LETHAL DOSE 50; LIPOPEPTIDES; MICE; MICROBIAL SENSITIVITY TESTS; PAENIBACILLUS; POLYMYXIN B; PSEUDOMONAS AERUGINOSA; TANDEM MASS SPECTROMETRY;

EID: 84863173784     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.05580-11     Document Type: Article

References (47)

1. Bliss CI. 1938. The determination of the dosage-mortality curve from small numbers. Q. J. Pharm. Pharmacol. 11:192-216.
2. Breukink E, et al. 1999. Use of the cell wall precursor lipid II by a pore-forming peptide antibiotic. Science 286:2361-2364. (Pubitemid 30016902)
3. Brogden KA. 2005. Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria? Nat. Rev. Microbiol. 3:238-250. (Pubitemid 40298223)
4. Clinical and Laboratory Standards Institute. 2009. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, approved standard, 8th ed, CLSI document M7-A8. CLSI, Wayne, PA.
5. Clinical and Laboratory Standards Institute. 2008. Performance standards for antimicrobial susceptibility testing: eighteenth informational supplement M100-S18. CLSI, Wayne, PA.
6. Falagas ME, Kasiakou SK, Saravolatz LD. 2005. Colistin: the revival of polymyxins for the management of multidrug-resistant gram-negative bacterial infections. Clin. Infect. Dis. 40:1333-1341. (Pubitemid 40570245)
7. Falla TJ, Karunaratne DN, Hancock REW. 1996. Mode of action of the antimicrobial peptide indolicidin. J. Biol. Chem. 271:19298-19303. (Pubitemid 26271598)
8. Fujii K, Ikai Y, Oka H, Suzuki M, Harada K. 1997. A nonempirical method using LC/MS for determination of the absolute configuration of constituent amino acids in a peptide: combination of Marfey's method with mass spectrometry and its practical application. Anal. Chem. 69:5146-5151.
9. Giske CG, Monnet DL, Cars O, Carmeli Y. 2008. Clinical and economic impact of common multidrug-resistant gram-negative bacilli. Antimicrob. Agents Chemother. 52:813-821. (Pubitemid 351358357)
10. Hamad B. 2010. The antibiotics market. Nat. Rev. Drug Discov. 9:675-676.
11. Hancock REW. 1997. The bacterial outer membrane as a drug barrier. Trends Microbiol. 5:37-42. (Pubitemid 27077171)
12. Hancock REW, Sahl HG. 2006. Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies. Nat. Biotechnol. 24:1551-1557. (Pubitemid 44967479)
13. Hashizume H, Nishimura Y. 2008. Cyclic lipopeptide antibiotics. Stud. Nat. Prod. Chem. 35:693-751.
14. Ibrahim HR, Sugimoto Y, Aoki T. 2000. Ovotransferrin antimicrobial peptide (OTAP-92) kills bacteria through a membrane damage mechanism. Biochim. Biophys. Acta 1523:196-205.
15. Jerala R. 2007. Synthetic lipopeptides: a novel class of anti-infectives. Expert Opin. Invest. Drugs 16:1159-1169. (Pubitemid 47317009)
16. Kato T, Shoji T. 1980. The structure of octapeptin D. (Studies on antibiotics from the genus Bacillus. XXVIII.) J. Antibiot. 33:186-191. (Pubitemid 10066234)
17. Kondejewski LH, Farmer SW, Wishart DS, Hancock REW, Hodges RS. 1996. Gramicidin S is active against both gram-positive and gram-negative bacteria. Int. J. Pept. Protein Res. 47:460-466. (Pubitemid 26267053)
18. Konishi M, et al. 1983. Bu-2470, a new peptide antibiotic complex. I. Production, isolation and properties of Bu-2470 A, B1 and B2. J. Antibiot. 36:625-633. (Pubitemid 13067618)
19. Lautenbach E, Patel JB, Bilker WB, Edelstein PH, Fishman NO. 2001. Extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae: risk factors for infection and impact of resistance on outcomes. Clin. Infect. Dis. 32:1162-1171. (Pubitemid 32390110)
20. Li J, Beatty PK, Shah S, Jensen SE. 2007. Use of PCR-targeted mutagenesis to disrupt production of fusaricidin-type antifungal antibiotics in Paenibacillus polymyxa. Appl. Environ. Microbiol. 73:3480-3489. (Pubitemid 46871435)
21. Li J, et al. 2006. Colistin: the emerging antibiotic for multidrug-resistant Gram-negative bacterial infections. Lancet Infect. Dis. 6:589-601.
22. Li J, Turnidge J, Milne R, Nation RL, Coulthard K. 2001. In vitro pharmacodynamic properties of colistin and colistin methanesulfonate against Pseudomonas aeruginosa isolates from patients with cystic fibrosis. Antimicrob. Agents Chemother. 45:781-785. (Pubitemid 32182025)
23. Loh B, Grant C, Hancock REW. 1984. Use of the fluorescent probe 1-N-phenylnaphthylamine to study the interactions of aminoglycoside antibiotics with the outer membrane of Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 26:546-551. (Pubitemid 14018094)
24. Malmsten M, Kasetty G, Pasupuleti M, Alenfall J, Schmidtchen A. 2011. Highly selective end-tagged antimicrobial peptides derived from PRELP. PLoS One 6:e16400.
25. Meyers E, et al. 1973. EM49, a new peptide antibiotic. 3. Biological characterization in vitro and in vivo. J. Antibiot. 26:457-462.
26. Meyers E, Parker WL, Brown WE. 1976. A nomenclature proposal for the octapeptin antibiotics. J. Antibiot. 29:1241-1246.
27. Mogi T, Kita K. 2009. Gramicidin S and polymyxins: the revival of cationic cyclic peptide antibiotics. Cell. Mol. Life Sci. 66:3821-3826.
28. Nordmann P, Poirel L, Toleman MA, Walsh TR. 2011. Does broad-spectrum β-lactam resistance due to NDM-1 herald the end of the antibiotic era for treatment of infections caused by Gram-negative bacteria? J. Antimicrob. Chemother. 66:689-692.
29. Owen RJ, Li J, Nation RL, Spelman D. 2007. In vitro pharmacodynamics of colistin against Acinetobacter baumannii clinical isolates. J. Antimicrob. Chemother. 59:473-477. (Pubitemid 47073453)
30. Paulus H, Gray E. 1964. The biosynthesis of polymyxin B by growing cultures of Bacillus polymyxa. J. Biol. Chem. 239:865-871.
31. Pirri G, Giuliani A, Nicoletto SF, Pizzuto L, Rinaldi AC. 2009. Lipopeptides as anti-infectives: a practical perspective. Cent. Eur. J. Biol. 4:258-273.
32. Reddy K, Yedery R, Aranha C. 2004. Antimicrobial peptides: premises and promises. Int. J. Antimicrob. Agents 24:536-547. (Pubitemid 39536106)
33. Rosenthal KS, Swanson PE, Storm DR. 1976. Disruption of Escherichia coli outer membranes by EM 49. A new membrane active peptide antibiotic. Biochemistry 15:5783-5792. (Pubitemid 8016834)
34. Rotem S, et al. 2008. Analogous oligo-acyl-lysines with distinct antibacterial mechanisms. FASEB J. 22:2652-2661.
35. Selim S, Negrel J, Govaerts C, Gianinazzi S, Van Tuinen D. 2005. Isolation and partial characterization of antagonistic peptides produced by Paenibacillus sp. strain B2 isolated from the sorghum mycorrhizosphere. Appl. Environ. Microbiol. 71:6501-6507. (Pubitemid 43194129)
36. Shoji J, Hinoo H, Sakazaki R. 1976. The constituent amino acids and fatty acid of antibiotic 333-25. (Studies on antibiotics from the genus Bacillus. XII.) J. Antibiot. 29:521-525.
37. Shoji J, et al. 1980. Isolation of octapeptin D. (Studies on antibiotics from the genus Bacillus. XXVII.) J. Antibiot. 33:182-185. (Pubitemid 10066233)
38. Srinivas N, et al. 2010. Peptidomimetic antibiotics target outer-membrane biogenesis in Pseudomonas aeruginosa. Science 327:1010-1013.
39. Storm DR, Rosenthal KS, Swanson PE. 1977. Polymyxin and related peptide antibiotics. Annu. Rev. Biochem. 46:723-763. (Pubitemid 8252143)
40. Sugawara K, et al. 1983. Bu-2470, a new peptide antibiotic complex. II. Structure determination of Bu-2470 A, B1, B2a and B2b. J. Antibiot. 36:634-638. (Pubitemid 13067619)
41. Terabe S, Konaka R, Shoji J. 1979. Separation of polymyxins and octapeptins by high-performance liquid chromatography. J. Chromatogr. A 173:313-320. (Pubitemid 9198293)
42. Tsubery H, et al. 2005. Neopeptide antibiotics that function as opsonins and membrane-permeabilizing agents for gram-negative bacteria. Antimicrob. Agents Chemother. 49:3122-3128. (Pubitemid 41060549)
43. Vaara M, et al. 2008. Novel polymyxin derivatives carrying only three positive charges are effective antibacterial agents. Antimicrob. Agents Chemother. 52:3229-3236.
44. Velkov T, Thompson PE, Nation RL, Li J. 2010. Structure-activity relationships of polymyxin antibiotics. J. Med. Chem. 53:1898-1916.
45. Wu X, et al. 2011. Paenibacillus tianmuensis sp. nov., isolated from soil. Int. J. Syst. Evol. Microbiol. 61:1133-1137.
46. Wu XC, et al. 2011. Paenimacrolidin, a novel macrolide antibiotic from Paenibacillus sp F6-B70 active against methicillin-resistant Staphylococcus aureus. Microb. Biotechnol. 4:491-502.
47. Zhang LJ, Dhillon P, Yan H, Farmer S, Hancock REW. 2000. Interactions of bacterial cationic peptide antibiotics with outer and cytoplasmic membranes of Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 44:3317-3321. (Pubitemid 33014325)